Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Profoto in connection with the listing on Nasdaq Stockholm
Mandate

Vinge advises Profoto in connection with the listing on Nasdaq Stockholm

July 02, 2021 Capital Markets and Public M&A M&A

Vinge advises Profoto Holding AB (publ) in connection with the listing on Nasdaq Stockholm. The prospectus was published on 21 June 2021 and the first day of trading on Nasdaq Stockholm was 1 July 2021. The offering price was SEK 66 per share, corresponding to a market value of approximately SEK 2,6 billion.

The Vinge team mainly includes Christian Lindhé, Erik Sjöman, Martin Svanberg and Nora Gullberg (Capital Markets and Public M&A) and Anna Edström and Lena Westberg (M&A).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026